➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Express Scripts
Harvard Business School
McKesson
Boehringer Ingelheim

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

VIRAZOLE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Virazole, and what generic alternatives are available?

Virazole is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in VIRAZOLE is ribavirin. There are fifteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ribavirin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Virazole

A generic version of VIRAZOLE was approved as ribavirin by ZYDUS PHARMS USA on October 28th, 2005.

  Try it Free

Drug patent expirations by year for VIRAZOLE
Drug Prices for VIRAZOLE

See drug prices for VIRAZOLE

Recent Clinical Trials for VIRAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
U.S. Army Medical Research and Development CommandPhase 2
Bausch Health Americas, Inc.Phase 1
Weill Medical College of Cornell UniversityEarly Phase 1

See all VIRAZOLE clinical trials

Pharmacology for VIRAZOLE
Paragraph IV (Patent) Challenges for VIRAZOLE
Tradename Dosage Ingredient NDA Submissiondate
VIRAZOLE FOR SOLUTION;INHALATION ribavirin 018859 2014-05-22

US Patents and Regulatory Information for VIRAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 AN RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VIRAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 ⤷  Try it Free ⤷  Try it Free
Bausch VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 ⤷  Try it Free ⤷  Try it Free
Bausch VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Express Scripts
Harvard Business School
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.